Pancreatic cancer survival prediction via inflammatory serum markers

BACKGROUND: For prognostic evaluation of pancreatic ductal adenocarcinoma (PDAC), the only well-established serum marker is carbohydrate antigen CA19-9. To improve the accuracy of survival prediction, we tested the efficacy of inflammatory serum markers. METHODS: A preoperative serum panel comprisin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanki, Mira, Seppänen, Hanna, Mustonen, Harri, Salmiheimo, Aino, Stenman, Ulf-Håkan, Salmi, Marko, Jalkanen, Sirpa, Haglund, Caj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374786/
https://www.ncbi.nlm.nih.gov/pubmed/35034144
http://dx.doi.org/10.1007/s00262-021-03137-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374786/
https://www.ncbi.nlm.nih.gov/pubmed/35034144
http://dx.doi.org/10.1007/s00262-021-03137-6

Ejemplares similares